Â¥
18.39
Nov 29
New Key Statistics Module, Z-Score and F-Score
SZSE:000623 Key Ratios
Market Cap ¥ M | 21,932.26 |
Enterprise Value ¥ M | 20,976.71 |
P/E(ttm) | 14.98 |
PE Ratio without NRI | 14.17 |
Forward PE Ratio | -- |
Price/Book | 0.76 |
Price/Sales | 6.98 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 19.17 |
Payout Ratio % | 0.46 |
Revenue (TTM) ¥ M | 3,004.00 |
EPS (TTM) ¥ | 1.23 |
Beneish M-Score | -2.3 |
10-y EBITDA Growth Rate % | 1.50 |
5-y EBITDA Growth Rate % | 6.90 |
y-y EBITDA Growth Rate % | -32.60 |
EV-to-EBIT | 13.62 |
EV-to-EBITDA | 13.62 |
PEG | 2.05 |
Shares Outstanding M | 1,195.90 |
Net Margin (%) | 47.58 |
Operating Margin % | 0.33 |
Pre-tax Margin (%) | 47.47 |
Quick Ratio | 1.82 |
Current Ratio | 2.24 |
ROA % (ttm) | 4.38 |
ROE % (ttm) | 5.10 |
ROIC % (ttm) | 0.03 |
Dividend Yield % | 4.40 |
Altman Z-Score | 4.93 |
SZSE:000623 Number of Guru Trades
SZSE:000623 Volume of Guru Trades
Gurus Latest Trades with SZSE:000623
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000623 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jilin Aodong Pharmaceutical Group Co Ltd Insider Transactions
No Available Data